FDA Clears WellDoc DiabetesManager system

WellDoc has received FDA 510(k) clearance to market the WellDoc DiabetesManager system to healthcare providers and their adult patients with type 2 diabetes.

The FDA has cleared WellDoc’s mobile health system to offer automated clinical coaching and behavioral algorithms driven by real-time patient data, according to the Baltimore-based company. The software-based system allows healthcare professionals to configure parameters by utilizing mobile phones and the internet.

The DiabetesManager captures, stores and transmits blood glucose data and other diabetes self-management information, which is then analyzed by the company’s Automated Expert Analytics system that delivers educational and behavioral patient coaching and provider decision support, WellDoc said.

 

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup